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Abstract
Background: Genital warts are a common and highly contagious sexually transmitted disease. They have a large
economic burden and affect several aspects of quality of life. Incidence data underestimate the real occurrence of
genital warts because this infection is often under-reported, mostly due to their specific characteristics such as the
asymptomatic course.
Methods: Genital warts cases for the analysis were obtained from the Catalan public health system database (SIDIAP)
for the period 2009-2016. People under 15 and over 94 years old were excluded from the analysis as the incidence of
genital warts in this population is negligible. This work introduces a time series model based on a mixture of two
distributions, capable of detecting the presence of under-reporting in the data. In order to identify potential
differences in the magnitude of the under-reporting issue depending on sex and age, these covariates were included
in the model.
Results: This work shows that only about 80% in average of genital warts incidence in Catalunya in the period
2009-2016 was registered, although the frequency of under-reporting has been decreasing over the study period. It
can also be seen that this issue has a deeper impact on women over 30 years old.
Conclusions: Although this study shows that the quality of the registered data has improved over the considered
period of time, the Catalan public health system is underestimating genital warts real burden in almost 10,000 cases,
around 23% of the registered cases. The total annual cost is underestimated in about 10 million Euros respect the 54
million Euros annually devoted to genital warts in Catalunya, representing 0.4% of the total budget.
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Background
Health information systems are essential to ensure the
safety and quality of health care and improve adherence to
clinical practice guidelines, but they are also a very pow-
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erful tool concerning resources management and con-
trol, decision making, and effective and efficient planning
of prevention and control interventions [1, 2]. However,
the incompleteness and inaccuracy of the information is
common in this type of registries and can lead to prob-
lems at a clinical level, but also at a population level such
as the underestimation of some diseases. In Catalunya
(Spain), the Information System for Research in Primary
Care (SIDIAP) was launched in 2010 with the integra-
tion of data from the clinical work station of primary
care (ECAP) of the Catalan Health Institute (ICS), which
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started in 1998, and other complementary sources [3]. The
ICS is the main provider of health services in Catalunya
and manages 283 out of 370 Primary Care Teams with a
catchment of 5,564,292 people, approximately 74% of the
Catalan population (http://ics.gencat.cat/es/lics/). Never-
theless, it is reasonable to assume that the incidence of
genital warts (GW) will be very similar among the Catalan
population not covered by ICS. In the particular case
of sexually transmitted diseases, it is even more impor-
tant to have reliable information due to their remarkable
morbidity, and therefore, the importance of controlling
trends over time and priority setting (see [4] for a com-
prehensive discussion focused on developing countries).
GW are a common and highly contagious sexually trans-
mitted disease in Catalunya (in 2016 the incidence was
about 107 cases per 100,000 women and 139 cases per
100,000men[5]) caused by a subset of HPV types, with the
most common being genotypes 6 and 11. They are usu-
ally benign, or non-cancerous, skin growths that develop
on the genital area. However, they have an important
negative impact on the health service and the individ-
ual, in addition to have a large economic burden and
affect several aspects of quality of life [6–8]. A higher
risk of CIN2+ lesions in women following a GW diag-
nose has been reported in a comprehensive recent study,
even more than four years after the GW diagnose [9]. It
is well known that incidence data underestimate, to some
degree, the real occurrence of genital warts because this
infection is often under-reported, mostly due to their spe-
cific characteristics such as the asymptomatic course of
the disease [10]. This issue might be even more severe
in specific vulnerable populations as imprisoned women
[11]. Further, the SIDIAP database only includes data
from the public healthcare sector and around 28% of
the general population in Catalunya have a double health
insurance coverage, public and private, so this fact can
also explain why GW incidence rates are underestimated
[12], although this source of under-reporting cannot be
detected by the proposedmodel as we only have data from
the public health system. There has been a growing inter-
est in the past recent years to deal with data that are only
partially registered or under-reported in the biomedical
literature [13–18]. Most of these previous works deal with
discrete-valued time series, whereas this paper is focused
on the incidence of a disease, which should be treated as a
continuous-valued time series. Therefore, the aim of this
work is to quantify the under-reporting of genital warts
cases in Catalunya and the reconstruction of the actual
incidence in the period 2009-2016 on the basis of the
mixture model described in the next Section.
Methods
Population and incidence estimation
The study population included all residents in Catalunya
assigned to an ICS primary care center (74% of the Catalan
population). Monthly GW incident cases for the analysis
were obtained from the SIDIAP database for the period
2009-2016. Episodes of GW were classified as incident if
they were preceded by at least 12-month period without
any episode. People under 15 and over 94 years old were
excluded from the analysis as the incidence of GW in this
population is negligible (averages of 0.24 cases and 0.22 x
100,000 individuals over the period of study respectively).
Model
Consider Xt the series of real GW incidence, where t =
1, 2, . . . is the time, following a normal distribution with
mean μ and variance σ 2. In our setting, this process can-




Xt with probability 1 − ωt
q · Xt with probability ωt (1)
The series Yt represents the registered values correspond-
ing to GW incidence in the part of Catalunya covered
by ICS. According to Eq. (1), the registered observations
series Yt is a mixture of two normally distributed ran-
dom variables Yt = Y1t with probability (1 − ωt) and
Yt = Y2t with probability ωt , where Y1t coincides with
the unobserved process Xt and Y2t is a normal random
variable with mean q · μ and variance q2 · σ 2. The
parameter ωt is modeled as logit(ωt) = α0 + α1 · t and
can be interpreted as the frequency of under-reporting
at a time t, while q can be interpreted as the intensity
of such under-reporting, both taking values between 0
and 1. When q = 0 the observed incidence is Yt = 0
and when q = 1 there is no under-reporting. A value of
ωt equal to 0 indicates that the observed value at time
t is not under-reported, and a value of ωt equal to 1
means that under-reporting is for sure happening. In
order to detect potential differences in GW incidence
depending on sex (men and women) and age (16-29 and
30-94), these covariates were included in the model, so
the mean of the observed process Y1t was modeled as
μ1,t = β0 +β1 · t+β2 · a+β3 · s+β4 · a ∗ s (where a is the
age, s is the sex and a ∗ s is the interaction between age
and sex). The average of the second component Y2t can be
recovered asμ2,t = q ·(β0+β1 · t+β2 ·a+β3 ·s+β4 ·a∗s).
After fitting the previous model and performing residuals
examination, a seasonal behavior with period 3 months
was observed. Hence the model was updated by includ-
ing the following trigonometric function to reflect this
periodic behavior: f (t) = β5 · sin
( 2·π ·t
3
) + β6 · cos ( 2·π ·t3 )
on the terms μ1,t and μ2,t . Other similar models were
considered and the best fitting one according to the
validation process described in the next Section was
chosen. In particular, as coefficients β1 and β6 are not
significant, models without linear trend and with only
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one periodicity term were considered but the resulting
validations were not satisfactory. Therefore, the final
expressions were μ1,t = β0 + β1 · t + β2 · a + β3 · s +
β4 · a ∗ s + β5 · sin
( 2·π ·t
3
) + β6 · cos ( 2·π ·t3 ) and μ2,t = q ·(








. The estimates and their associated
standard errors were obtained by maximizing the log-
likelihood function described in Eq. (2) and from its
Hessian matrix respectively, using the nlm procedure in R
[19].














where Y = y1, . . . , yn is the observed series, θ =
(α0,α1, γ ,β0, . . . ,β6, σ), ωt = eα0+α1t1+eα0+α1t , q = e
γ
1+eγ andμ1,t
and μ2,t are as defined before.
In order to get proper initial values for themaximization
routine, an Expectation-Maximization (EM) algorithm for
mixtures of linear regressions was used, through the R
package mixtools [20]. The estimates provided by the EM
algorithm could have been used directly, but although
this methodology is widely used when dealing with mix-
tures of distributions, it is unable to produce standard
errors directly [21], and this is an important drawback
in our context and in many other situations. If the main
focus was not on quantifying the under-reporting issue,
an alternative approach to analyze these data might be a
hierarchical generalized linear model with random effects
[22], implemented in the R package HGLMM [23]. By
means of this methodology the most likely unobserved
real GW incidence process is reconstructed based on the
classification (underreported or not underreported) given
by the posterior probabilities for the observations, pro-
vided by the output of themixtools procedure, and on the
estimates of the parameters. All the R code used to fit the
models and to obtain the reported results and figures is
available as Supplementary material.
Validation
The goodness of fit of the proposed mixture approach
can be assessed by means of the Akaike’s Information
Criterion (AIC) compared to a single normal model.
In this case, this measure favors the proposed model
(AIC: 1717.9) in front of the single normal model (AIC:
1826.1). The model has been validated by analyzing its
residuals. Figure 1 shows that they behave like white
noise as expected and that there are no significant auto-
correlations that should be accounted for. The residuals rt
have been estimated as
r̂t = Yt −
(
ω̂t · q̂ ·
(
β̂0 + β̂1 · t + β̂2 · a + β̂3 · s + β̂4 · a ∗ s + β̂5 · sin
(





2 · π · t
3
))
+ (1 − ω̂t) ·
(
β̂0 + β̂1 · t + β̂2 · a + β̂3 · s + β̂4 · a ∗ s
+β̂5 · sin
(
2 · π · t
3
)
+ β̂6 · cos
(
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Fig. 1 Auto-correlations and partial auto-correlations of the model residuals















Fig. 2 Residuals qqplot
where Yt is the total observed GW incidence at time
t, and the letters with a hat (̂) represent the estimated
parameters.
If we were dealing with counts (number of cases) instead
of incidence, the underlying distribution might be a Pois-
son, although the monthly number of GW cases is large
enough to be approximated by a normal distribution.
Additionally, the assumption that the underlying distribu-
tions of the two processes are Gaussian seems reasonable
considering the qqplot of the residuals shown in Fig. 2.
Results
Our analysis estimates that, globally, only around 80%
of actual GW incidence was registered in the SIDIAP
database in the period 2009-2016. For women over 30
years old, the monthly average registered incidence is 3.9
cases per 100,000 women, while the estimated monthly
incidence is 4.9 cases per 100,000 women, 24.9% higher.
On males over 30 years old, the registered series has a
monthly average of 5.9 cases per 100,000 men for 7.1
cases per 100,000 men on the reconstructed series, 21.8%
higher. Regarding males under 30 years old, the recon-
structed series is 13.3% higher (monthly averages of 18.4
and 20.8 cases per 100,000 men for the registered and
reconstructed processes respectively). For women under
30 years old, the monthly average registered incidence of
GW in Catalunya is 19.0 per 100,000 women, while the
reconstructed hidden process has an average of 23.0 cases
per 100,000 women, about 21.0% larger. This information
is summarized in Table 1 and described in more detail in
the Supplementary material (Table S1).
Table 2 shows the estimated effect of the age and sex
over the under-reporting issue. In particular, it can be seen
that the GW incidence is higher among younger popu-
lations and men. It can also be noticed that a significant
interaction between sex and age group is found, which can
be interpreted as a distinguishable impact of sex on GW
incidence depending on the age group.
Table 1 Registered and estimated GWmonthly average incidence (number of cases x 100,000 individuals) in the period 2009-2016
Sex Age Incidence (registered) Incidence (estimated) Difference (%)
15-29 19.0 23.0 21.0%
Females 30-94 3.9 4.9 24.9%
Average 6.8 8.4 23.2%
15-29 18.4 20.8 13.3%
Males 30-94 5.9 7.1 21.8%
Average 8.3 9.8 18.3%
Global 7.6 9.1 19.9%
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Table 2 Parameter estimates
Covariate Parameter Estimate (95% CI)
α0 2.99 (1.77; 4.20)
t α1 -4.31 (-6.53; -2.09)
β0 13.76 (7.11; 20.40)
t β1 0.36 (-12.75; 13.46)
age β2 -13.53 (-14.13; -12.92)
sex β3 -1.60 (-2.24; -0.95)
age ∗ sex β4 3.25 (2.44; 4.06)
β5 4.16 (0.44; 7.88)
β6 0.52 (-5.59; 6.64)
q 0.75 (0.72; 0.77)
Figure 3 shows the registered (solid black line) and
reconstructed unobserved (dashed red line) processes for
each of the considered sub-populations. Although this
figure shows increasing trends for all series, they are
not well explained by coefficient β1, which is not signif-
icantly different from zero. Increasing trends are mainly
explained by the significant coefficient α1, which leads to
a decreasing frequency of under-reporting ωt .
The under-reporting frequency is about 95% in 2009
(ω1) and around 21% in 2016 (ω96). This is measured by
parameter α1 in model (1), and should not be confused to
overall under-reporting of the data, as its intensity (mea-
sured by parameter q in the model) also plays a crucial
role. For instance, all observations in a certain period of
time could be slightly under-reported (ω = 1, q near
to 1), resulting in small differences between registered
and estimated values or just a few observations might be
under-reported (ω near to zero) but with a high intensity
(q near to zero), potentially resulting on large differences
between registered and estimated values. Table 3 shows
the total number of GW cases registered in the SIDIAP in
the period of study, the reconstructed values according to
these registered cases and the projection over the whole
Catalan population, assuming that the incidence on the
area outside ICS coverage is the same.
Discussion
The results of this work show that in relative terms,
the under-reporting issue has a deeper impact on people
over 30 years old (where GW incidence is lower), espe-
cially among women. Nonetheless, the relative difference
between registered and estimated annual averages range













































































Fig. 3 Registered (solid black line) and estimated underlying series (dashed red line) for each of the considered sub-populations
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Table 3 Registered, estimated and projected number of GW cases in Catalunya
Sex Age SIDIAP (registered) SIDIAP (estimated) Catalunya (registered projection) Catalunya (estimated projection)
15-29 8,051 9,769 10,280 12,460
Females 30-94 7,625 9,520 9,062 11,337
Total 15,676 19,289 19,342 23,797
15-29 7,967 9,097 10,166 23,797
Males 30-94 10,774 13,842 12,914 16,598
Total 18,741 22,939 23,080 28,182
Global 34,417 42,228 42,422 51,979
between 13.3% and 24.9%. It is also remarkable that the
quality of SIDIAP register regarding GW in Catalunya has
been significantly improving during the study period, as
the frequency of under-reported observations has been
decreasing over time. Facing under-reported information
from public health registers is very common in many
situations, especially regarding potentially asymptomatic
diseases like GW. The proposed methodology considers
the potential under-reporting in continuous time series
data in a very flexible way, estimating its frequency and
intensity, and it is general enough to be appropriate in a
wide range of real situations in the public health context.
Additionally, the most likely non-observed process can be
reconstructed on the basis of estimated posterior proba-
bilities. Moreover, the GW data show that these models
can deal with time-dependent under-reporting parame-
ters, seasonal behavior, trends and also incorporate the
effect of other factors by including covariates.
One of the potential limitations of this study is that
the database used included data from the public health-
care setting and not from the private sector. In Catalunya,
it is estimated that 33% of women and 25% of men
aged 15 to 44 years have a double health insurance
coverage (i.e. the public health insurance and a pri-
vate insurance plan) [12], so the rates estimated in our
study are likely still underestimating the real incidence
of GW. One of its strengths is that the same method-
ology (possibly with minor model modifications) could
be used to analyze the frequency and intensity of poten-
tial under-reporting issues for any condition or set-
ting in the absence of temporal dependence among the
observations.
Conclusions
The GW incidence registered in SIDIAP is underestimat-
ing the real burden in almost 10,000 cases in Catalunya,
around 23% of the registered cases. The annual per person
cost of GW was around 1000 Euros [8], so the poten-
tial total annual cost is underestimated in at least about
10 million Euros respect the 54 million Euros devoted to
GW in Catalunya annually, representing 0.4% of the total
budget of the Catalan Government intended for health,
although about 2.8 million Euros would correspond to pri-
vate insurances. It is, therefore, clear that knowing the true
burden of GW at the general population level is impor-
tant for health policy makers, especially after the intro-
duction of prophylactic vaccines against HPV in many
countries, as it plays a crucial role in developing and eval-
uating prevention strategies [24, 25]. This work presents
a methodology that opens a wide field for future research
lines. In particular, if temporal correlations are found in
the data, an appropriate model should take this structure
into account, similarly to [13, 18].
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